fbpx

We are currently recruiting for the following studies:

  • The treatment of women with pudendal neuralgia or vulvodynia with topical Mi-Gel 
  • Treatment of vaginal dryness in post-menopause women including breast cancer survivors
  • Treatment of hot flushes in women during or after breast cancer
  • Investigational treatment for Uterine Fibroids
  • Hyaluronic acid for the treatment of Perineal Pain/Pudendal Neuralgia
  • For more information please contact us today, noting which study you are interested in.

  • All studies have been approved by the Human Research Ethics Committee (HREC)

     

Efficacy of Mi-Gel in the treatment of women with pudendal neuralgia or vulvodynia 

The study aim is to assess the effectiveness and safety of the application of a topical cream to reduce the impact of pain on daily life compared to placebo. Each participant will trial MiGel and the placebo for a period of 3 months each, without knowing which cream you are applying until after the completion of the study. A visit to our city clinic is required 4 times (first appointment, 10 days later, 3 months and 6 months). 

For full details or contact Dr Karen Chan, Principal Investigator, or Liz Howard, research assistant via support@whria.com.au

Main inclusion criteria

  • Women over 18 years old with vulvodynia or pudendal neuralgia for greater than 3 months
  • Not used topical amitriptyline on the vulva for 6 weeks 

Treatment of vaginal dryness in post-menopause women including breast cancer survivors

The study aim is to assess the effectiveness and safety of a new, non-hormonal, at home, self-use ultrasound device (Madorra Therapy System). If you have had your last menstrual period at least 12 months ago and are interested in participating, please contact Jinzhu Liu, research coordinator jz.liu@unsw.edu.au

Main inclusion criteria

  • Adult women between the ages of 22 and 70 experiencing vaginal dryness
  • Women with menopause defined by natural amenorrhea or treatment-induced (includes but is not limited to chemotherapy, ovarian hormonal suppression) with last menstrual period at least 12 months ago, or surgical removal of ovaries. Breast cancer survivors can be in the study
  • Physically able to apply an ultrasound Madorra device to the vulva without assistance
  • Be sufficiently competent in English

Treatment of hot flushes in women during or after breast cancer

The study aim is to assess the effectiveness and safety of a new medication to treat frequent hot flushes and night sweats in women who have a history of or current breast cancer. 

Do you suffer from frequent hot flushes and night sweats with breast cancer? Are you being treated with tamoxifen or aromatase inhibitors?

If yes, you may be eligible to participate in this study investigating a new drug to treat flushing symptoms in women with, or survivors of breast cancer. 

Main inclusion criteria

Female aged between 18 to 70 years
Have a history of or current breast cancer
On a stable dose of tamoxifen or an aromatase inhibitor for a minimum of one month, and no anticipated change in the dose for the study duration of approximately eight weeks
Experience an average of at least 50 moderate to severe hot flushes per week

Please contact Ms Jinzhu Liu, study director on 0402 388 707 or email jz.liu@unsw.edu.au or A/Prof John Eden on support@whria.com.au For technical details please click this link

Hyaluronic acid for the treatment of Perineal Pain/Pudendal Neuralgia

The purpose of this study is to determine the effectiveness of pudendal nerve blocks with hyaluronic acid in the treatment of perineal pain. If you suffer from pain in the vagina, vulva, perineum, penis or scrotum, you may be eligible for this study. Please contact Liz Howard via support@whria.com.au for information to enrol.

Congratulations to WHRIA’s Dr Lauren Kite, the recipient of the Robert Wrigley Pain Research Scholarship, 2018-2019. This grant will fund the study Randomised cross-over trial assessing the efficacy of adding hyaluronic acid to local anaesthetic in pudendal nerve blocks

For more information please contact us today.

Investigational treatment for Uterine Fibroids

The study aim is to reduce heavy menstrual bleeding and assess the safety and efficacy of the treatment of uterine fibroids.

If you or anyone you know is suffering from Uterine Fibroids, with symptoms of heavy menstrual bleeding and pelvic discomfort, and:

• are 18 years or older with at least 1 uterine fibroid documented by ultrasound at screening with largest diameter ≥30 mm and <120 mm
• have heavy menstrual bleeding >80.0 mL
If you are interested in further information or participating in the study, please contact Dr Jinzhu Liu, Research Manager via jz.liu@unsw.edu.au

Women who are pregnant, lactating or have hemoglobin values ≤6 g/dL are not eligible.

If you have a specific enquiry for our WHRIA specialists

Click Here

Privacy Policy for Research Participants

Any information about you that is obtained in connection with a research study will remain confidential and will be disclosed only with your permission. To ensure confidentiality, your information will be identified only by initials, date of birth and a study allocated number. The results of the study may be published or disclosed to other people in a way that will not identify you. The study will be conducted in accordance all relevant national and international regulatory guidelines to minimise negative impact on participants. Your medical records insofar as they relate to this study may be reviewed by officials of government related bodies or of any commercial company involved in this study. However, no personal details will be released. All data will be stored by the Women’s Health & Research Institute of Australia, under controlled (locked) access. Data will be retained for a minimum of ten years. Materials (including paper documents and computer discs) will be destroyed using an industrial shredding process.

If you have a specific enquiry for our WHRIA specialists

Click Here

© 2014 Women's Health & Research Institute of Australia. Privacy Policy | Terms of Use